Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Other financing activities (2018 - 2022)

Historic Other financing activities for Puma Biotechnology (PBYI) over the last 3 years, with Q4 2022 value amounting to $69000.0.

  • Puma Biotechnology's Other financing activities changed N/A to $69000.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $69000.0, marking a year-over-year decrease of 6682.69%. This contributed to the annual value of $277000.0 for FY2022, which is 8549.74% down from last year.
  • Latest data reveals that Puma Biotechnology reported Other financing activities of $69000.0 as of Q4 2022.
  • In the past 5 years, Puma Biotechnology's Other financing activities ranged from a high of $1.9 million in Q3 2021 and a low of $9000.0 during Q4 2018
  • For the 3-year period, Puma Biotechnology's Other financing activities averaged around $439200.0, with its median value being $69000.0 (2022).
  • Examining YoY changes over the last 5 years, Puma Biotechnology's Other financing activities showed a top increase of 9722.51% in 2022 and a maximum decrease of 9722.51% in 2022.
  • Over the past 3 years, Puma Biotechnology's Other financing activities (Quarter) stood at $9000.0 in 2018, then soared by 21122.22% to $1.9 million in 2021, then plummeted by 96.39% to $69000.0 in 2022.
  • Its last three reported values are $69000.0 in Q4 2022, $53000.0 for Q3 2022, and $155000.0 during Q1 2022.